Results 111 to 120 of about 81,715,714 (308)

University Hospitals Staff Meeting Bulletin, October 25, 1934

open access: yes, 1934
University of Minnesota. University of Minnesota Hospitals. (1934). University Hospitals Staff Meeting Bulletin, October 25, 1934.
University of Minnesota. University of Minnesota Hospitals
core  

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

open access: yesMolecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche   +10 more
wiley   +1 more source

University Hospitals Staff Meeting Bulletin, April 23, 1936

open access: yes, 1936
University of Minnesota. University of Minnesota Hospitals. (1936). University Hospitals Staff Meeting Bulletin, April 23, 1936.
University of Minnesota. University of Minnesota Hospitals
core  

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

open access: yesMolecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi   +6 more
wiley   +1 more source

Non-specialized inpatient care provided by university hospitals in Japan

open access: yesRisk Management and Healthcare Policy, 2008
Shin-ichi ToyabeCrisis Management Office, Niigata University Hospital, Niigata City, JapanAbstract: In Japan, all citizens are covered by the national insurance system in which universal free access to healthcare services is promised to everybody.
Shin-ichi Toyabe
doaj  

University Hospitals General Staff Meeting, February 4, 1932

open access: yes, 1932
University of Minnesota. University of Minnesota Hospitals. (1932). University Hospitals General Staff Meeting, February 4, 1932.
University of Minnesota. University of Minnesota Hospitals
core  

Partial FAK suppression promotes tumor growth, an effect reversed by macrophage p110δ PI3K inactivation

open access: yesMolecular Oncology, EarlyView.
Partial inhibition of focal adhesion kinase (FAK) can paradoxically promote tumor growth, rather than simply producing a weaker antitumor effect than that observed with strong FAK suppression. In breast cancer and melanoma models, targeting p110δ PI3K, particularly in macrophages, counteracted these tumor‐promoting effects, highlighting the importance ...
Lydia Xenou   +4 more
wiley   +1 more source

Potential drug-drug interactions in a Brazilian teaching hospital: age-related differences?

open access: yesRevista de Ciências Farmacêuticas Básica e Aplicada, 2015
This study proposes to measure frequency and to characterize the profile of potential drug interactions (pDDI) in a general medicine ward of a teaching hospital.
Daniela Oliveira de Melo   +2 more
doaj  

University Hospitals General Staff Meeting, February 5, 1931

open access: yes, 1931
University of Minnesota. University of Minnesota Hospitals. (1931). University Hospitals General Staff Meeting, February 5, 1931.
University of Minnesota. University of Minnesota Hospitals
core  

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

open access: yesMolecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy